In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula ...

You wouldn’t think that Episode 14 of a 16-episode run was necessarily the right place for a significant change of pace, but ...

The latest Call of Duty fumbles its much-anticipated campaign, while zombies and multiplayer modes retain the status quo.

Welcome to this week’s ForbesWomen newsletter, which every Thursday brings news about the world’s top female entrepreneurs, ...

In the third part of “On the Calculation of Volume,” Solvej Balle continues to tell the story of a woman trapped in the 18th ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

The 2025 Formula 1 season has moved into its business end with the title still very much up for grabs. Lando Norris made the perfect start to his title challenge in Australia as he looks to dethrone ...

article argues that the pervasive censorship of 'mainstream' AI models like Claude and ChatGPT necessitates the work of ...